u266 b1 human multiple myeloma b lymphocyte cell line (ATCC)
Structured Review
U266 B1 Human Multiple Myeloma B Lymphocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1677 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/u266+cell+line/U266B1/pm41898552-244-1-13
Average 97 stars, based on 1677 article reviews
Images
Related Articles
Cell Culture:Article Title: Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms. Article Snippet: .. An Article Title: Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs. Article Snippet: Multiple myeloma (MM) progression and drug resistance depend on the crosstalk between MM cells and bone marrow (BM) fibroblasts (FBs).. During monoclonal gammopathy of undetermined significance (MGUS) toMM transition, MM cell-derived exosomes (EXOs) reprogram the miRNA (miR) profile of FBs, inducing the overexpression miR-23b3p, miR-27b-3p, miR-125b-5p, miR-214-3p, and miR-5100.. Here, we demonstrate that the miR content of MM FB-derived EXOs (FB-EXOs) overlaps the miR profile of parental FBs by overexpressing comparable levels of miR-23b-3p, miR-27b-3p, miR-125b-5p, miR-214-3p, and miR-5100. Article Title: Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms Article Snippet: .. An Article Title: Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones Article Snippet: For this assay, we procured mouse anti-human IgG1 CD138 (Exbio, clone A-38, Cat #, cat# 10-520-C100, Czech Republic), rabbit anti-human IgG CD56 (Invitrogen, cat # 701379), and directly conjugated mouse anti-human CD45-Alexa647 (AbD Serotec, act# MCA87A647, Raleigh, NC, USA) along with mouse anti-human Alexa Fluor ® 555 (Invitrogen, Waltham, MA, USA) and goat anti-rabbit Alexa FluorPLUS ® 488 (Invitrogen, Waltham, MA, USA) secondary antibodies targeting CD138 and CD56 respectively. .. |

